Mesothelioma treatment options improve early detection

How can receive with other forms of the disease early diagnosis of mesothelioma improve a patient a total forecast. This applies especially for mesothelioma cancer because the majority of cases at a stage of development be diagnosed if only palliative treatment options are discussed.

Fight of rare cancer mesothelioma can be extremely difficult for patients for a number of reasons. Response to treatment can seriously hamper a patient's factors such as age, stage of the cancer and overall physical health.

Receiving a diagnosis of malignant mesothelioma is hard in general how many doctors mesothelioma as Diagnostics due to the similarity with its symptoms to other diseases can see. Another factor that complicates detection and diagnosis is serious latency use associated with the symptoms. Most patients don't start characters the cancer until 20 years to the first exposure to experience asbestos.

Although treatment is often limited to palliative measures instead of curative, early diagnosis can open options and a chance to fight against cancer the door to a variety of additional treatments.

If a patient is diagnosed during phase 1 or 2 rather than stage 3 or 4, a potentially curative surgery option. The key to get such is early diagnosis constantly to look for investigations, to check for signs of asbestos.

Those who may come into contact with asbestos in the past encouraged to disclose such information to your doctor. If possible, the consultation with a doctor is the experienced in the signs of asbestos or dealing with mesothelioma is most advantageous.

Additional information about Mesothelioma or asbestos can be found through the mesothelioma Center.

This entry was on Thursday, December 16, 2010 at 10: 05 am and is filed under asbestos exposure, mesothelioma. You can follow RSS feed any responses to this entry through the. You are currently closed trackback responses, but from your own site.

View the original article here

Mesothelioma improves tumor detection using PET scanner during surgery

Mesothelioma is a rare form of cancer that has been historically difficult to detect and diagnose. Researchers at Memorial Sloan Kettering Cancer Center have however recently found that handheld Positron Emission Tomography (PET) scans can detect smaller tumors during operation at a better rate than traditional PET scans.

During a study with mice with malignant mesothelioma the handheld PET scans inoculated lesions adopted, discovered reliably that mesothelioma. This statement can help surgeons better resect primary and metastatic tumors.

PET scans make use of the metabolic processes of cells to create highly detailed images of internal body. Each test is undergoing a PET scan intravenously injected with a solution of radioactive glucose. Your body with equipment that can detect the presence of radioactive glucose will be scanned during the test.

Researchers who have been part of the study said: "this novel tool be used synergistically with imaging PET scan could fabric selection to maximize intraoperatively." The accuracy and visibility offered by the handheld PET scan can again extend survive a patient as a whole and prognosis.

Current treatment options for mesothelioma palliative and no definitive cure available. Often enough the average life expectancy for mesothelioma patients due to the late detection between 4 and 18 months after diagnosis.

Learn more about Mesothelioma can be found through the mesothelioma Center.

This entry was on Wednesday, December 8th, 2010 at 4: 29 pm and is filed under treatment mesothelioma, mesothelioma, mesothelioma research. You can follow RSS feed any responses to this entry through the. You are currently closed trackback responses, but from your own site.

View the original article here

The early detection of mesothelioma may provide new screening tests.

Exciting findings that may allow early detection and treatment of pancreatic cancer and mesothelioma were revealed in an American Association of cancer research meeting in Denver on 28. Somalogic, Inc, privately developed the new screening technology.

The technology is based on aptamers - bits of genetic material, the proteins stick. The study tested enterprise Explorer blood samples from patients with cancer both in the control groups that had conditions the you symptoms similar to these types of cancer such as pancreatitis or lung fibrosis.

According to Rachel Ostroff, Director of clinical research of Somalogic Inc., the team of biological markers that were to realize high-precision in any type of cancer found. Now the biomarker must be confirmed in other studies to ensure that the results were exactly and reliably in diagnostic tests can be reproduced. "It's very easy to discover biomarkers," Ostroff said the session. "It is very difficult to verify."
If these tests can provide early detection, it would be an exciting new weapon in detecting and treating mesothelioma kills an estimated 15,000 to 20,000 people worldwide every year.

View the original article here